Selling And Administration Expenses Alterar Data
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
Alterity Therapeutics Limited AUD 2.29M 649.1K 2023-06
Assertio Holdings USD 20.8M 4.03M 2023-09
Cara Therapeutics USD 6.72M 790K 2023-09
Cassava Sciences USD 4.28M 468K 2023-09
Chugai Pharma JPY 27.54B 5.72B 2023-09
Cipla INR 10.91B 245.2M 2023-09
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.29M 163K 2023-09
CSL USD 1.29B 219.4M 2023-06
Grifols EUR 300.32M 28.7M 2023-09
Halozyme Therapeutics USD 37.61M 2.34M 2023-12
J&J USD 5.81B 410M 2023-12
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
Pacira USD 65.8M 2.15M 2023-12
Pfizer USD 4.47B 1.27B 2023-12
RedHill Biopharma USD 8.06M 2.85M 2023-06
Revance Therapeutics USD 67.73M 8.62M 2023-09
Supernus Pharmaceuticals USD 81.28M 1.42M 2023-12
Vanda Pharmaceuticals USD 28.4M 7.7M 2023-06



Cara Therapeutics Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.